What is the purpose of this trial?
The purpose of this research study is to see if oral everolimus is tolerable and effective in the treatment of sporadic Angiomyolipomas (AMLs). AMLs are the most common non-cancerous tumor of the kidney. They are composed of blood vessels, muscle cells and fat cells.Everolimus is already an approved drug for several other diseases like kidney cancer, but is being studied now specifically to see if it is helpful for people with AML.
Fox Chase Cancer Center
Dates: 05/23/2017 - 12/01/2017
Last Updated: 06/11/2017
Study HIC#: 1603017389